Analyst Reco. AstraZeneca PLC Nasdaq Stockholm

Equities

Real-time Estimate Cboe Europe Other stock markets 14:22:10 28/06/2024 BST			5-day change	1st Jan Change
1,670 ^SEK	+0.66%		+0.33%	+23.20%

06-27	US FDA declines to approve Merck-Daiichi's 'guided missile' cancer drug	RE
06-26	European Equities Close Lower in Wednesday Trading	MT

ASTRAZENECA : Deutsche Bank sticks Neutral	06-26	ZD
ASTRAZENECA : Goldman Sachs reiterates its Buy rating	06-25	ZD
ASTRAZENECA : Barclays maintains a Buy rating	06-24	ZD
ASTRAZENECA : Goldman Sachs maintains a Buy rating	06-18	ZD
Global markets live: AstraZeneca, Apple, Meta, Microsoft, Cisco...	06-17
ASTRAZENECA : Berenberg raises its price target	06-10	CF
AstraZeneca shares outperform, Berenberg raises target	06-10	CF
Berenberg Raises AstraZeneca PT, Maintains Buy Rating	06-10	MT
Berenberg Raises Price Target on AstraZeneca to GBP150 From GBP130, Cites More Confidence in Longer-Term Outlook, Keeps Buy Rating	06-10	MT
JPMorgan cuts Aviva but lifts M&G	06-10	AN
ASTRAZENECA : Berenberg gives a Buy rating	06-10	ZD
ASTRAZENECA : JP Morgan reiterates its Buy rating	06-07	ZD
HSBC Raises AstraZeneca PT, Keeps Buy Rating	06-05	MT
ASTRAZENECA : Deutsche Bank remains Neutral	06-05	ZD
ASTRAZENECA : Goldman Sachs reiterates its Buy rating	06-05	ZD
Berenberg raises Taylor Wimpey to 'buy'	06-05	AN
ASTRAZENECA : UBS reiterates advice after ASCO meeting	06-04	CF
ASTRAZENECA : Gets a Sell rating from UBS	06-04	ZD
ASTRAZENECA : JP Morgan remains its Buy rating	06-03	ZD
Goldman Sachs Starts AstraZeneca With Buy Rating, $97 Price Target	05-30	MT

No results for this search

ASTRAZENECA : Strong Q1 raises hopes of a guidance upgrade

April 25, 2024 at 05:02 pm